XAIR
Beyond Air·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 4
Stock Price Surged Significantly
Consensus Rating "Strong Buy"
Ample Liquidity
Negative Gross Margin
Price Hits New Low
Price Hits 52-week Low
RSI Oversold
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About XAIR
Beyond Air, Inc.
A medical device and biopharmaceutical company focused on the treatment of respiratory conditions
Healthcare Equipment and Supplies
04/24/2015
05/07/2019
NASDAQ Stock Exchange
61
03-31
Common stock
900 Stewart Avenue, Suite 301, Garden City, NY 11530
--
Beyond Air, Inc., incorporated under the laws of the State of Delaware on April 24, 2015, is an emerging medical device and biopharmaceutical company developing a nitric oxide (NO) generator and delivery system, or AIT NO generator and delivery system, capable of producing NO from the surrounding air. AIT NO generators and delivery systems can generate up to 400 parts per million (" ppm ") for delivery to the patient's lungs. The AIT NO generator and delivery system can deliver NO continuously or for a fixed period of time, and can titrate or maintain a constant dose as needed.
Earnings Call
Q1/2026
Estimate EPS--
Actual EPS-0.53
Estimate Revenue1.75M
Actual Revenue1.76M
Beyond Air's 2026 Q1: Navigating Contradictions in International Sales, Tariffs, and Growth Prospects
Aug 12,2025 07:46
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
XAIR has released its 2026 Q2 earnings. EPS was reported at -1.25, versus the expected -0.26, missing expectations. The chart below visualizes how XAIR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
XAIR has released its 2026 Q2 earnings report, with revenue of 1.82M, reflecting a YoY change of 127.82%, and net profit of -8.26M, showing a YoY change of 41.14%. The Sankey diagram below clearly presents XAIR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
